🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
9.95
-0.62 (-5.87%)
At close: Nov 20, 2026, 4:00 PM EST
10.07
+0.12 (1.21%)
After-hours: Nov 20, 2026, 7:54 PM EST

Summit Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
150.81225.27104.8671.43348.6171.79
Short-Term Investments
478.98488.18307.49114.82--
Cash & Short-Term Investments
629.79713.45412.35186.24348.6171.79
Cash Growth
164.00%73.02%121.41%-46.58%385.59%8.09%
Accounts Receivable
----0.351.46
Other Receivables
---0.855.7715.7
Receivables
---0.856.1217.16
Prepaid Expenses
30.636.5411.082.621.57.16
Restricted Cash
0.320.320.33-300-
Other Current Assets
----0.491.2
Total Current Assets
660.73720.3423.75189.71656.7197.31
Property, Plant & Equipment
21.1921.687.46.065.083.48
Goodwill
1.9821.861.891.82.01
Other Intangible Assets
-----10.4
Other Long-Term Assets
8.967.212.555.280.580.17
Total Assets
692.85751.18435.56202.95664.17113.37

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
32.7220.294.642.670.364.37
Accrued Expenses
71.8347.0331.5314.2116.3111.32
Current Portion of Long-Term Debt
----19.77-
Current Portion of Leases
3.853.393.772.811.691.09
Current Unearned Revenue
-----7.94
Other Current Liabilities
1.832.281.80.720.660.9
Total Current Liabilities
110.2372.9941.7320.4138.7825.62
Long-Term Debt
---100494.54-
Long-Term Leases
16.1317.53.453.292.761.69
Other Long-Term Liabilities
1.811.831.631.561.432.78
Total Liabilities
128.1792.3246.81125.26537.5130.09

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
87.757.387.022.110.98
Additional Paid-In Capital
3,4672,9481,5981,066504.77384.05
Retained Earnings
-2,908-2,294-1,215-993.26-378.33-299.55
Comprehensive Income & Other
-2.7-2.54-2.29-2.45-1.89-2.2
Shareholders' Equity
564.68658.86388.7577.69126.6583.28
Total Liabilities & Equity
692.85751.18435.56202.95664.17113.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
19.9820.897.22106.1518.762.78
Net Cash (Debt)
609.81692.56405.1380.14-170.1669.01
Net Cash Growth
161.58%70.95%405.51%--4.63%
Net Cash Per Share
0.780.930.560.13-0.880.75
Filing Date Shares Outstanding
799.76775.37737.68701.7697.6998.12
Total Common Shares Outstanding
799.73775.37737.63701.66211.0998.04
Working Capital
550.5647.31382.02169.31617.9371.69
Book Value Per Share
0.710.850.530.110.600.85
Tangible Book Value
562.71656.86386.8875.8124.8670.88
Tangible Book Value Per Share
0.700.850.520.110.590.72
Machinery
---0.921.391.37
Leasehold Improvements
---0.330.810.37
SEC Filings: 10-K · 10-Q